The purpose of this research study is t assess the safety and effectiveness of a long-acting form of somatostatin (lanreotide, Ipstyle@) as a treatment of patients with acromegaly, the condition caused by excessive growth hormone secretion by a pituitary adenoma (benign tumor). The study is sponsored by Ipsen Biotech and will involve eighty patients at several different institutions, including approximately ten at the University of Pennsylvania.
Showing the most recent 10 out of 423 publications